Biophore receives sub-license from MPP to manufacture and market molnupiravir for COVID treatment
365telugu.com online news,Hyderabad, 21 January 2022: Biophore India Pharmaceuticals has announced that it has received license from Medicines Patent Pool (MPP) on behalf of originator company MSD, a trade name…
